Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution ...Middle East

EINDHOVEN, Netherlands, Nov. 3, 2020 /PRNewswire/ -- Salvia BioElectronics B.V. ("Salvia"), a neurostimulation platform company targeting chronic migraine, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its implantable...

Hence then, the article about salvia bioelectronics receives fda breakthrough device designation for innovative neurostimulation solution was published today ( Tuesday 03/11/2020 - 11:20 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution )

Also on site :

• Cyberattack hits Canvas system used by thousands of schools as finals loom
• Philadelphia Soccer 2026 otvára akreditácie médií a registráciu fanúšikov na festival fanúšikov FIFA Fan Festival™ vo Philadelphii
• China Innovative Drug NHWD-870 Receives Breakthrough Therapy Designation, Bringing New Hope of Survival to NUT Carcinoma Patients